CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-11-03 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −980 | $39.19 | $38K | 167,618 |
| 2022-11-03 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −3,920 | 1,399,635 | ||
| 2022-11-02 | Schlanger David J Executive Chairman | Exercise or conversion | +41,667 | $0.91 | $38K | 124,215 |
| 2022-11-02 | Schlanger David J Executive Chairman | Sale | −17,167 | $40.62 | $697K | 107,048 |
| 2022-11-02 | Schlanger David J Executive Chairman | Sale | −15,683 | $41.64 | $653K | 91,365 |
| 2022-11-02 | Schlanger David J Executive Chairman | Sale | −8,517 | $42.56 | $362K | 82,848 |
| 2022-11-02 | Schlanger David J Executive Chairman | Sale | −300 | $43.68 | $13K | 82,548 |
| 2022-11-02 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) | −41,667 | 1,275,346 | ||
| 2022-11-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +16,000 | $3.95 | $63K | 266,445 |
| 2022-11-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −6,640 | $40.62 | $270K | 259,805 |
| 2022-11-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −6,014 | $41.66 | $251K | 253,791 |
| 2022-11-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −3,266 | $42.59 | $139K | 250,525 |
| 2022-11-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −80 | $43.68 | $3K | 250,445 |
| 2022-11-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −1,660 | $40.62 | $67K | 170,938 |
| 2022-11-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −1,504 | $41.66 | $63K | 169,434 |
| 2022-11-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −816 | $42.59 | $35K | 168,618 |
| 2022-11-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −20 | $43.68 | $874 | 168,598 |
| 2022-11-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −16,000 | 1,403,555 | ||
| 2022-11-01 | Schlanger David J Executive Chairman | Exercise or conversion | +41,667 | $0.91 | $38K | 124,215 |
| 2022-11-01 | Schlanger David J Executive Chairman | Sale | −35,655 | $44.08 | $1.6M | 88,560 |
Page 36 of 77 · 1,524 trades